New CEO Brase puts $511K of his own money into Conagra at $14.59
CAG sits 18% above its 52-week low of $12.53.
Summary
New Conagra CEO John Brase purchased $511K of company stock at $14.59 per share, his first open-market buy since taking over, signaling personal commitment to the turnaround.
Key Events · Ownership and Investor Activity · CAG
-
CEO Open-Market Purchase
President and CEO John Brase bought 35,000 shares for $510,632.50 at $14.59 per share on July 17, 2026, his first reported transaction as CEO.
-
Financial Impact
The $511K purchase represents a significant personal investment by the new CEO, though it is a small fraction of the company's $7.1 billion market cap.
-
Turnaround Context
The purchase follows a $1.92 billion net loss, a dividend cut, and below-consensus guidance, with Brase recently signaling potential portfolio divestitures.
-
Insider Alignment
As a new CEO, this open-market buy aligns Brase's interests with shareholders and demonstrates confidence in his strategic review, expected in early 2027.
Analysis · CAG · Manufacturing
Just days after taking the helm, John Brase bought 35,000 shares for $510,632.50 at $14.59 each—his first open-market purchase as CEO. The move lands immediately after Conagra slashed its dividend, reported a massive impairment-driven loss, and issued weak guidance. By putting his own capital on the line, Brase delivers a tangible signal that he is committed to the turnaround he has been hinting at in recent interviews.
How filings like this one have moved
In the 30 days to Sep 18, 2026, 29.1% of the 1692 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CAG was trading at $14.82 on NYSE in the Manufacturing sector, with a market capitalization of approximately $7.1B. The 52-week trading range was $12.53 to $20.32. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.